CytoPherx
Ann Arbor
About CytoPherx
CytoPherx (formerly Nephrion) clinical stage medical device company addressing inflammation-based diseases and conditions. The company’s products are custom configurations of a proprietary selective cytopheresis-based inflammation modulating system.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $50.2M
- Funding stage: Late Stage Venture
- Last round: Series C (Jan 2012)
- Website: cytopherx.com
- Phone: +1 734-272-4772
Industries & Categories
Health Care, Life Science, Medical Device
Canonical: https://fsome.com/organization/cytopherx-1488171 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.